StockTipsArenaBeta

BUY Honasa Consumer — Rajesh Satpute

BUYHonasa Consumer
Honasa Consumer share price target & all analyst calls

byRajesh SatputeHorizon: NA (inferred Swing (≤2wk))13 Aug 2026via CNBC Awaaz.

Entry₹480.7Inferred
Target₹500
Total upside +4.01% (call closed)
Stop loss₹470-2.23% risk
Exit₹50014 Aug 2026, 9:25 am
Target hit+4.01%0.00%upside left
Follow Rajesh Satpute for new calls(32% target hit, 200 closed calls)Get alertsWatch HONASA for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 14 Aug 2026
10 supporting3 neutral0 opposing
Supports the BUY call (10)

Honasa Consumer Q1: Jefferies, Citi Raise Targets, But Stay Split On Whether Growth Can Last

NewsNdtv-Profit·14 Aug · today

(opens in new tab)

Honasa Consumer shares in focus after solid Q1 performance — Analysts mixed, two raise price targets

NewsCnbc-Tv18·14 Aug · today

(opens in new tab)

Honasa Consumer Q1 Results: Mamaearth parent posts record profit of Rs 90 crore; revenue up 27% YoY

NewsEt-Markets·13 Aug · today

(opens in new tab)

Honasa Consumer Q1 net profit more than doubles as general, modern trade grow over 40%

NewsCnbc-Tv18·13 Aug · today

(opens in new tab)

Honasa Consumer Q1 Results: Mamaearth Parent Posts Over 2x Jump In Profit; Margin Expands Sharply

NewsNdtv-Profit·13 Aug · today

(opens in new tab)
Neutral / worth noting (3)

Honasa Consumer Ltd announced the outcome of its Board Meeting held on August 13, 2026. The Board approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 20

BSE · Board Meeting·13 Aug · today

(opens in new tab)

Honasa Consumer expects no financial impact from Dubai court ruling

NewsGoogle News·8 Aug · 5d ago

(opens in new tab)

Mirae Asset Research Spotlights Honasa, Gland Pharma, Bata, Siemens

NewsGoogle News·4 Aug · 1w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Honasa Consumer

All analyst calls on Honasa Consumer

More from Rajesh Satpute

Every call and its outcome